Forbes Best Customer Service, Powered by HundredX

We proudly continue our partnership with Forbes by powering the Forbes Best Customer Service list, which spotlights the brands that customers have singled out for their exceptional customer service. We congratulate the 300 companies that stand out from more than 3,000 brands across 80 industries within the HundredX coverage universe. These rankings are calculated on 4.2 million pieces of feedback from 201,000 customers, measuring a variety of factors including the effectiveness of the people, technology, and processes businesses put in place to ensure their customers have successful outcomes.

Through this process, we identified four critical dimensions of customer service: 

Customer Service is Vital to the Customer Journey

This year's results underscore a crucial trend in the modern marketplace: the integral role of customer service in brand perception and loyalty. The top-ranking companies on this list, including The UPS Store, Chick-fil-A, REI, and USAA, exemplify a commitment not only to operational excellence but also to creating meaningful connections with their customers. They understand that even in today’s digital age, a personal touch makes a significant difference. 

Discover More Information

At HundredX, we believe in the power of listening to the wisdom of “the crowd”. Our collaboration with Forbes on this list is a testament to our commitment to bringing forward insights that matter. For businesses looking to elevate their customer service, the Forbes Best Customer Service list serves as a valuable guide and inspiration.


We invite you to delve into the insights offered by this year's list and encourage businesses to reach out to us for guidance on how to be part of this distinguished group. With HundredX's expertise, your brand can transform customer feedback into actionable strategies that drive success and customer satisfaction.

Share This Article

06 May, 2024
Sure, lattes, mochaccinos, and cappuccinos are pricey, but they taste delicious. For many consumers, the great taste of coffee shop coffee made it worth the cost. But customers at Starbucks aren't so sure the tradeoff is worth it anymore. Examining more than 420,000 pieces of feedback across the Quick, Fast, Casual (QFC) industry, including over 21,000 on Starbucks, we find: Starbuck's Purchase Intent 1,2 is down 3% over the past six months, with most of that dip occurring over the past few months. By contrast, Dunkin' Donuts has remained within a tight range over the past six months, as did an average of other, smaller coffee chains. Customers increasingly see less value in Starbucks. Starbuck's Value perception 3 fell 5% over the past six months, compared to just 1% for Dunkin' Donuts. However, it also fell 5% for the average of the smaller coffee chains. Coffee drinkers feel significantly unhappier about Starbuck's quality and taste. Starbuck's Taste perception fell 4% over the past six months, while rising 1% for competitors. Likewise, its Quality perception dipped 3% over the same time period (and 8% over the year). Ultimately, Starbuck's perceived drop in taste is leading inflation-weary consumers to say they plan to spend less at the coffee chain, as the value just isn't as good.
06 May, 2024
Forbes Best Brands for Social Impact, Powered by HundredX
06 May, 2024
Ozempic once dominated the headlines, but GLP-1 competitor Mounjaro is winning over customers. GLP-1 drugs, used for treating diabetes and aiding in weight loss, are relatively new on the market yet have surged in popularity over the last year. They're becoming so popular that J.P. Morgan estimates that 30 million people in the US may be using a GLP-1 drug by 2030. This statistic presents a significant potential for early drug creator Novo Nordisk (Ozempic, Wegovy), and perhaps an even bigger one for Eli Lilly (Mounjaro, Zepbound). HundredX data indicates Eli Lilly is in a position to win over Novo Nordisk as Mounjaro's Usage Intent widens against the competition. Ozempic may have name recognition, but customers feel more positively about Mounjaro's effectiveness and lifestyle impact, even if they aren't excited about its high price. Examining 1,500 pieces of customer feedback across Mounjaro, Ozempic, and Wegovy, we find: GLP-1 users increasingly say they plan to use Mounjaro more, and Ozempic less . Mounjaro’s Usage Intent is up 19% since July, Wegovy’s is up 3%, and Ozempic has stayed within a tight range. Customers feel Mounjaro is more effective than competing drugs, but it’s harder to get . Mounjaro outperforms other GLP-1 drugs in effectiveness, lifestyle impact, and side effects. However, customers dislike its cost and availably more than competitors.
Share by: